medigraphic.com
SPANISH

Revista Clínica de la Escuela de Medicina de la Universidad de Costa Rica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

Next >>

Rev Clin Esc Med 2018; 8 (2)

Cefalea por abuso de medicamentos

Gómez VLE, Chang SJL, Fernández MH
Full text How to cite this article

Language: Spanish
References: 26
Page: 11-17
PDF size: 378.73 Kb.


Key words:

Headache, Medication-overuse, Tensional migraine, Secondary headache, NSAID, Pharmacological treatment.

ABSTRACT

Medication-overuse headache corresponds to a phenomenon of chronification and aggravation of symptoms in patients with primary headaches, mainly migraine or tension headache, who consume, frequently, relief drugs. This disorder reaches a prevalence around 1 to 2% in general population. The following is a clinical review of the etiology, pathophysiology, epidemiology, diagnosis and management of this condition, which is highly frequent in general and specialized medical consultations.


REFERENCES

  1. Kristoffersen E Lundqvist C. Medicationoveruse headache: epidemiology, diagnosis and treatment. Therapeutic Advances in Drug Safety. 2014; 5(2): 8-99.

  2. IHS. III edición de la clasificación internacional de las cefaleas UK: SAGE; 2013.

  3. Westergaard M Hansen E Glumer C Olesen J Jensen R. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia. 2013; 34(6): 409-425.

  4. Westergaard M Hansen E Glumer C Olesen J Jensen R. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014; 155: 2005- 2013.

  5. Thorlund K Sun-Edelstein C Kanters E,et al. Risk of medication overuse headache across classes of treatments for acute migraine. The journal of Headache and Pain. 2016; 17(107): 696-698.

  6. Lipton R. Risk Factors for and Management of Medication-Overuse Headache. Continuum. 2015; 21(4): 1181-31.

  7. Diener H Holle D Solbach K Gaul C. Medication- overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016; 12: 575-583.

  8. Jay G Barkin R. Primary Headache Disorders- Part 2: Tension-type headache and medication overuse headache. Dis Mon. 2017; 17.

  9. Ropper A Samuels M Klein J. Adams y Victor Principios de Neurología. In.: McGraw Hill; 2016: 168-197.

  10. Srikiatkhachorn A Maneesri S Supornsilpchai W Storer J. Pathophysiology of Medication Overuse Headache—An Update. Headache. 2014; 205:204-10.

  11. Rossi C Pini L Cupini M Sarchielli P. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur. J. Clin. Pharmacol. 2008; 64: 1-8

  12. Todd J Schwedt Chong. Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research. Headache. 2017; 130 (37): 1173-1178.

  13. Ferraro S Grazzi L Mandelli M et al. Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med. 2012; 13(2): 255-262.

  14. Longo D Kasper D Jameson J Fauci A Hauser S Loscalzo J. Harrison principios de medicina interna. 18th ed. Mexico: McGraw Hill; 2012.

  15. Rossi P Di Lorenzo C Faroni J Cesarino F Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006; 26: 1097-105.

  16. Grande R Aaseth K Benth J Lundqvist C Russell M. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011; 18(1): 129-137.

  17. Abrams B. Medication Overuse Headaches. Med Clin North Am. 2013; 97(2): 337-352

  18. Evers S Jensen R. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur J Neurol. 2011; 18: 1115- 21.

  19. Paemeleire K Crevits L Goadsby P Kaube H. Practical management of medication-overuse headache. Acta neurol. belg. 2006; 106: 43-51.

  20. Garza I Schwedt T. Medication overuse headache: treatment and prognosis. Up to Date. [Online].; 2016 [cited 2017 Noviembre 27. Disponible en: https://www-uptodatecom. ezproxy.sibdi.ucr.ac.cr/contents/medicationoveruse- headache-treatment-and-prognosis? source=search_result&search=medication %20overuse%20headache&selectedTitle=2~74.

  21. Pageler L Katsarava Z Diener H Limmroth V. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia. 2008; 28(2): 152-156.

  22. Evers S Marziniak M. Clinical features, pathophysiology, and treatment of medicationoveruse headache. Lancet Neurol. 2010; 9: 391- 401.

  23. Rossi P Faroni J Tassorelli C Nappi G. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial.. J Headache Pain. 2013; 14(10): 1-8.

  24. Chinag C Schwedt T Wang S Dodick D. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016; 1(16): 371-86.

  25. Silberstein S. Practice parameter: evidencebased guidelines for migraine headache (an evidence- based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762.

  26. Westover M, Choi E, Awad K, Bianchi M. Pocket neurology. 2nd ed. Massachusetts: Wolters Kluwer; 2016.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Clin Esc Med. 2018;8